Sunil Healthcare

Sunil_Healthcare26 Apr 2024

Miscellaneous

₹

+4.02 (+5.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Sunil Healthcare

Sunil Healthcare

Miscellaneous

Sunil_Healthcare26 Apr 2024

₹

+4.02 (+5.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
09-Nov-2023	BC	Interalia approved Un-audited financial results(standalone and consolidated) for the 2nd quarter/1st half year ended September 30, 2023 Members of the Company have duly approved the Re-appointment	14-Aug-2024
06-Feb-2024	BC	Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Intimation of the Board Meeting of the Com	14-Feb-2024
09-Nov-2023	BC	Interalia approved Un-audited financial results(standalone and consolidated) for the 2nd quarter/1st half year ended September 30, 2023 Members of the Company have duly approved the Re-appointment	13-Feb-2024
09-Nov-2023	BC	Accorded the approval for postal Ballot Notice for seeking consent of the members of the Company for certain special Businesses viz re-appointment of Dr. Harish Pal Kumar (DIN: 01826010) as Non-exec	06-Jan-2024
01-Nov-2023	BC	Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Intimation of the Board Meeting scheduled	09-Nov-2023

No Rights has been declared by Sunil_Healthcare

Book Closure

Record Date	Split Date	Purpose
14-Aug-2024	-	Interalia approved Un-audited financial results(standalone and consolidated) for the 2nd quarter/1st half year ended September 30, 2023 Members of the Company have duly approved the Re-appointment
14-Feb-2024	-	Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Intimation of the Board Meeting of the Com
13-Feb-2024	-	Interalia approved Un-audited financial results(standalone and consolidated) for the 2nd quarter/1st half year ended September 30, 2023 Members of the Company have duly approved the Re-appointment
06-Jan-2024	01 Jan'1900	Accorded the approval for postal Ballot Notice for seeking consent of the members of the Company for certain special Businesses viz re-appointment of Dr. Harish Pal Kumar (DIN: 01826010) as Non-exec
09-Nov-2023	-	Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Intimation of the Board Meeting scheduled

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sunil Healthcare Ltd ₹84.47(+4.02/5.00%)	84.47	+4.02	86.62	35.39	0.00	1.52
MPIL Corporation Ltd ₹940.00(-9.90/-1.04%)	940.00	-9.90	53.58	252.06	81.17	3.47
Jaykay Enterprises Ltd ₹138.45(-4.60/-3.22%)	138.45	-4.60	809.35	169.62	137.08	5.65
Modi Rubber Ltd ₹103.50(+3.00/2.99%)	103.50	+3.00	259.16	72.21	11.75	0.68
FGP Ltd ₹7.60(-0.39/-4.88%)	7.60	-0.39	9.04	42.06	0.00	2.83
TCI Industries Ltd ₹1,300.00(0.00/0.00%)	1,300.00	+0.00	117.00	7.26	0.00	12.68

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	22.67	23.58	22.13	20.31	25.66	31.78
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	22.67	23.58	22.13	20.31	25.66	31.78
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.97	0.33	0.82	0.48	0.24	0.58
Total Income	25.64	23.91	22.95	20.79	25.90	32.36
Total Expenditure	23.31	22.39	21.06	17.61	22.65	26.40
PBIDT	2.33	1.52	1.89	3.18	3.25	5.96
Interest	1.44	1.31	1.27	1.17	1.07	1.10
PBDT	0.89	0.21	0.62	2.00	2.18	4.86
Depreciation	1.45	1.59	1.61	2.00	1.67	1.71
Tax	0.09	0.00	0.00	-0.07	0.09	0.64
Deferred Tax	-0.28	-0.37	-0.23	0.13	0.10	0.26
Reported Profit After Tax	-0.37	-1.02	-0.76	-0.05	0.31	2.25
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.37	-1.02	-0.76	-0.05	0.31	2.25

EPS (Unit Curr.)	-0.36	-0.99	-0.74	-0.05	0.31	2.19
EPS (Adj) (Unit Curr.)	-0.36	-0.99	-0.74	-0.05	0.31	2.19
Calculated EPS (Unit Curr.)	-0.36	-0.99	-0.74	-0.05	0.31	2.19
Calculated EPS (Adj) (Unit Curr.)	-0.36	-0.99	-0.74	-0.05	0.31	2.19
Calculated EPS (Ann.) (Unit Curr.)	-1.44	-3.98	-2.95	-0.21	1.23	8.77
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-1.44	-3.98	-2.95	-0.21	1.23	8.77
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.25	10.25	10.25	10.25	10.25	10.25
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.28	6.45	8.54	15.66	12.67	18.75
PBDTM(%)	3.93	0.89	2.80	9.85	8.50	15.29
PATM(%)	-1.63	-4.33	-3.43	-0.25	1.21	7.08

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	22.67	23.70	22.51	21.26	25.18	30.64
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	22.67	23.70	22.51	21.26	25.18	30.64
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	3.13	0.22	1.19	0.96	0.85	1.77
Total Income	25.80	23.92	23.70	22.22	26.03	32.41
Total Expenditure	23.30	22.48	21.69	18.53	23.17	26.57
PBIDT	2.50	1.44	2.01	3.68	2.86	5.85
Interest	1.44	1.31	1.27	1.17	1.07	1.10
PBDT	1.06	0.13	0.74	2.51	1.79	4.74
Depreciation	1.45	1.59	1.61	2.00	1.67	1.71
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.09	0.00	0.00	-0.07	0.09	0.65
Deferred Tax	-0.28	-0.37	-0.23	0.13	0.10	0.26
Reported Profit After Tax	-0.20	-1.10	-0.64	0.45	-0.08	2.13
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-0.20	-1.10	-0.64	0.45	-0.08	2.13

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.20	-1.10	-0.64	0.45	-0.08	2.13

EPS (Unit Curr.)	-0.20	-1.07	-0.63	0.44	-0.08	2.07
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.25	10.25	10.25	10.25	10.25	10.25

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	11.03	6.08	8.93	17.31	11.36	19.09
PBDTM(%)	4.68	0.55	3.29	11.81	7.11	15.47
PATM(%)	-0.88	-4.64	-2.84	2.12	-0.32	6.95

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	11.41	11.26	11.13	11.01	10.25	10.25
Reserves Total	51.47	44.53	37.82	37.52	38.88	38.54
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	62.88	55.79	48.95	48.53	49.13	48.79
Secured Loans	32.14	29.59	40.51	35.18	47.10	59.77
Unsecured Loans	3.49	4.09	8.44	13.51	7.98	0.85
Total Debt	35.63	33.68	48.95	48.69	55.08	60.62
Total Liabilities	98.51	89.47	97.90	97.22	104.21	109.41
APPLICATION OF FUNDS :
Gross Block	108.28	102.77	96.36	90.67	83.59	80.01
Less : Accumulated Depreciation	37.85	32.80	26.56	20.69	14.77	9.09
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	70.43	69.97	69.80	69.98	68.82	70.92
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.01	1.75	0.01	0.01	2.47	0.19
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	1.16	1.20	0.24	0.24	0.23
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	12.46	9.93	11.26	22.43	15.02	9.74
Sundry Debtors	35.51	22.00	27.79	28.63	41.38	47.98
Cash and Bank	3.37	3.23	7.77	4.83	2.57	4.67
Loans and Advances	2.06	2.01	4.56	7.21	8.36	7.01
Total Current Assets	53.39	37.17	51.38	63.11	67.33	69.40
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	16.47	12.49	17.08	28.74	27.22	24.60
Provisions	1.58	1.33	0.93	1.11	1.09	0.52
Total Current Liabilities	18.06	13.83	18.02	29.85	28.30	25.12
Net Current Assets	35.34	23.35	33.37	33.26	39.03	44.28
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	1.78	1.04
Deferred Tax Liability	7.90	6.81	5.55	5.52	7.86	7.08
Net Deferred Tax	-7.90	-6.81	-5.55	-5.52	-6.08	-6.04
Total Assets	97.88	89.42	98.83	97.96	104.48	109.58
Contingent Liabilities	0.03	0.03	0.03	0.03	0.00	0.04

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	11.41	11.26	11.13	11.01	10.25	10.25
Reserves Total	45.74	39.70	33.46	34.34	36.52	37.18
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	57.15	50.96	44.59	45.35	46.77	47.43
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	32.14	29.59	40.51	35.18	49.06	61.72
Unsecured Loans	3.49	4.09	8.44	13.51	6.02	-1.10
Total Debt	35.63	33.68	48.95	48.69	55.08	60.62
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	1.60	2.07	2.11	1.82	1.11	2.01
Total Liabilities	94.38	86.71	95.65	95.86	102.96	110.06
APPLICATION OF FUNDS :
Gross Block	108.29	102.78	96.36	90.67	83.60	80.01
Less: Accumulated Depreciation	37.86	32.81	26.56	20.70	14.77	9.09
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	70.43	69.97	69.80	69.97	68.83	70.92
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.01	1.75	0.01	0.01	2.47	0.19
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	1.03	1.07	0.11	0.11	0.10
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	13.60	11.05	13.73	24.86	16.60	10.13
Sundry Debtors	28.41	18.89	23.43	23.56	39.24	48.14
Cash and Bank	3.94	3.46	8.28	5.00	2.69	4.83
Loans and Advances	2.16	1.40	3.07	5.63	6.93	6.04
Total Current Assets	48.11	34.81	48.51	59.05	65.47	69.14
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	16.87	14.83	18.44	27.72	27.60	25.33
Provisions	1.63	1.33	0.93	1.12	1.09	0.77
Total Current Liabilities	18.50	16.17	19.37	28.84	28.69	26.10
Net Current Assets	29.61	18.64	29.14	30.21	36.78	43.05
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	1.78	1.04
Deferred Tax Liability	7.90	6.81	5.55	5.52	7.86	7.08
Net Deferred Tax	-7.90	-6.81	-5.55	-5.52	-6.08	-6.04
Other Assets	2.24	2.13	1.17	1.09	0.86	1.85
Total Assets
Contingent Liabilities	0.03	0.03	0.03	0.03	0.00	0.04

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.03	0.05	1.16	0.98	0.65
Net Cash from Operating Activities	7.13	21.89	16.63	4.18	15.07
Net Cash Used In Investing Activities	-3.40	-3.35	-11.33	-2.46	-3.08
Net Cash Used In Financing Activities	-3.75	-18.56	-6.42	-1.54	-11.66
Net Inc./Dec In Cash And Cash Equivalents	-0.02	-0.01	-1.12	0.18	0.33
Cash And Cash Equivalents At End Of The Year	0.02	0.03	0.05	1.16	0.98

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

73.53%

FII Shareholding

0.00%

DII Shareholding

0.10%

Public Shareholding

26.37%

**Promoter pledged shareholding 73.53%

About Sunil Healthcare Ltd

Sunil Healthcare Ltd is in the Miscellaneous sector, having a market capitalization of Rs. 86.62 crores. It has reported a sales of Rs. 22.67 crores and a net profit of Rs. -0.37 crores for the quarter ended December 2018. The company management includes Anil Kumar Khaitan, Anil Kumar Khaitan,Sanjay Kumar Kaushik,Rakesh Mohan,Harish Pal Kumar,Krishna Venkatachalam Ranjan,Mudita Chaturvedi,Bejon Kumar Misra,Satyendu Pattnaik (Sunil Healthcare Ltd) among others.

Chairman

Anil Kumar Khaitan

Registered office

38E/252-A 1st Flr,Vijay Tower Shahpurjat,New Delhi,New Delhi,110049

FAX :91-11-43850087

Background

Incorporation Year1973

Face Value₹10

Market Lot50

How to buy Sunil Healthcare shares on nse?

To buy Sunil Healthcare shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Sunil Healthcare share price today?

The Sunil Healthcare shares price on nse is Rs.84.47 today.

What is the market cap of Sunil Healthcare shares on BSE ?

The company has a market capitalization of Rs.86.62Cr

What is the PE & PB ratio of Sunil Healthcare shares ?

PE is 0 and PB is 1.52

What is the 52 Week High and Low of Sunil Healthcare shares?

Sunil Healthcare stock price high: Rs.84.47 Sunil Healthcare stock price low: Rs.45.65